Accelerating the development of commercial health insurance and stimulating investment in the biopharma sector are among China’s development objectives set for this year. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
